Holdings
William Blair Small Cap Growth Fund
As of Jun 30, 2026, William Blair Small Cap Growth Fund reported 89 positions worth US$1.19B. Largest: Diebold Nixdorf Incorporated, Krystal Biotech, Inc. and Veracyte, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Diebold Nixdorf Incorporated | 329K | US$28M | +6,069 | Jun 30, 2026 |
| Krystal Biotech, Inc. | 63,930 | US$23.8M | +8,140 | Jun 30, 2026 |
| Veracyte, Inc. | 394K | US$23.1M | +51,700 | Jun 30, 2026 |
| Cognex Corporation | 313K | US$22.7M | −38,430 | Jun 30, 2026 |
| Alignment Healthcare, Inc. | 949K | US$22.6M | +137K | Jun 30, 2026 |
| Flowserve Corporation | 286K | US$21.2M | +76,440 | Jun 30, 2026 |
| Establishment Labs Holdings Inc. | 247K | US$21.2M | +8,980 | Jun 30, 2026 |
| Regal Rexnord Corporation | 87,680 | US$20.9M | +3,170 | Jun 30, 2026 |
| Vericel Corporation | 469K | US$20.9M | +58,400 | Jun 30, 2026 |
| Primo Brands Corporation | 826K | US$20.2M | +9,136 | Jun 30, 2026 |